Andrew Bunston

Andrew Bunston  

Partner

Executive Summary

Andrew Bunston is a partner in the Securities and Capital Markets Group at our Toronto office and the national leader of our private equity practice. Andrew's practice focuses on corporate and securities law, including mergers and acquisitions and corporate finance. Andrew's practice encompasses:

  • Advising buyers, sellers and boards of directors in relation to mergers and acquisitions.
  • Advising clients in connection with securities law matters as well as general corporate and commercial law, including contracts, and corporate governance.
  • Advising both underwriters and issuers in various types of financings by public offering and private placement.
  • Advising on joint ventures and structuring of investments, including cross-border structures, limited partnerships, trusts and other investment vehicles.

Andrew has particular industry experience in financial services, investment management, REITs, retail, technology, mining, agriculture, and healthcare.

Andrew has seconded at the Ontario Securities Commission Corporate Finance and Take-Over Branch in 2006 and at two TSX-listed companies in 2010 and 2011.

Representative Work

Mergers and Acquisitions Transactions

  • Acting for a significant retirement home operator in connection with its sale to a private equity purchaser.
  • Acting for Cynapsus Therapeutics Inc. in connection with its $841-million going private transaction by way of plan of arrangement involving Sunovion Pharmaceuticals Inc.
  • Acting for a Canadian Schedule I bank in connection with the divestiture of various financial assets across multiple jurisdictions.
  • Acting for Oriole Media Corp. in connection with Yellow Pages Digital & Media Solutions Limited's $35 million acquisition of Juice Mobile.
  • Acting for Softchoice Corporation in connection with its $412-million going private transaction by way of plan of arrangement involving Birch Hill Equity Partners.
  • Acting for JLL Partners, Inc. in connection with its $1.4-billion acquisition of Patheon Inc.
  • Acting for a significant healthcare company in connection with its divestiture of various business segments.
  • Acting for Health Care REIT in connection with its $1-billion acquisition of HealthLease Properties REIT.
  • Acting for Parrish & Heimbecker, Limited in connection with its $95-million acquisition of Weyburn Inland Terminal Ltd.
  • Acting for Parrish & Heimbecker, Limited in connection with the sale of its food division, P&H Foods, to Exceldor Cooperative.
  • Acting for the principal shareholder of Acuity Funds Ltd. in connection with AGF Management Limited's $339-million acquisition of the Acuity group of companies.
  • Acting for Parsons Brinckerhoff Inc. in connection with its acquisition of Halsall Associates Ltd., an engineering and project management firm.
  • Acting for AIC Limited in connection with Manulife Financial Corporation's acquisition of AIC's retail investment fund business.
  • Acting for Hewlett-Packard in connection with the Canadian integration of various acquisitions including, its businesses resulting from its $13.9-billion acquisition of EDS.

Corporate Finance Transactions

  • Acting for Loblaw Companies Limited in connection with its issuance of $225-million of Second Preferred Shares, Series B.
  • Acting for Cynapsus Therapeutics Inc. in connection with its USD $72.5-million southbound-only offering of common shares under the MJDS.  The offering was the first southbound-only underwritten offering of equity securities by an issuer under MJDS.
  • Acting for the agents in connection with Cameco Corporation's $500-million offering of unsecured Series G debentures.
  • Acting for George Weston Limited in connection with its offering of $200-million of Senior Unsecured Notes, 2024.
  • Acting for Loblaw Companies Limited in connection with its issuance of $1.6-billion aggregate principal amount of Series 2019 and Series 2023 notes.
  • Acting for Titan Medical Inc. in connection with over $30 million of equity financings through prospectus offerings and private placements.
  • Acting for the agents in connection with a private placement of commercial mortgage pass-through securities in connection with the securitization of more than $200-million of commercial mortgage loans.
  • Acting for Loblaw Companies Limited and Choice Properties REIT in connection with the conveyance of approximately $7-billion of real estate assets by the Loblaw group to create Choice Properties REIT and the corresponding initial public offering of units of Choice Properties REIT and issuance of debentures.
  • Acting for the agents in connection with Cameco Corporation's $500-million offering of unsecured Series E and Series F debentures.
  • Acting for Northland Power Inc. in connection with its $150-million preferred share offering.
  • Acting for the underwriters in connection with Chartwell REIT's $130-million unit offering.
  • Acting for the dealer managers in connection with TimberWest Forest Corp.'s $150-million rights offering and private placement.
  • Acting for Loblaw Companies Limited in the establishment of a medium term note program and the issuance of $350-million principal amount of medium term notes under the new program.

Publications & Presentations

Rankings & Recognitions

  • ​Recognized in the 2017 edition of The Canadian Legal Lexpert® Directory (Corporate Mid-Market).​